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To investigate the role of peptide backbone confor-
mation on the biological activity of chemotactic pep-
tides, we synthesized a unique analog of N-formyl-
Met-Leu-Phe-OH incorporating the ca,a disubstituted 
residue, dipropylglycine (Dpg) in place of Leu. The 
conformation of the stereochemically constrained Dpg 
analog was examined in the crystalline state by x-ray 
diffraction and in solution using NMR, IR, and CD 
methods. The secretagogue activity of the peptide on 
human neutrophils was determined and compared with 
that of a stereochemically constrained, folded type II 
/j-turn analog incorporating 1-aminocyclohexanecar-
boxylic acid (Acsc) at position 2 (f-Met-Acsc-Phe-
OMe), the parent peptide (f-Met-Leu-Phe-OH) and its 
methyl ester derivative (f-Met-Leu-Phe-OMe). In the 
solid state, the Dpg analog adopts an extended /j-sheet-
like structure with an intramolecular hydrogen bond 
between the NH and CO groups of the Dpg residue, 
thereby forming a fully extended (C5) conformation at 
position 2. The q, and y; values for Met and Phe residues 
are significantly lower than the values expected for an 
ideal antiparallel {3 conformation causing a twist in the 
extended backbone both at the N and C termini. Nu-
clear magnetic resonance studies suggest the presence 
of a significant population of the peptide molecules in 
an extended antiparallel {3 conformation and the in-
volvement of Dpg NH in a C5 intramolecular hydrogen 
bond in solutions of deuterated chloroform and deuter-
ated dimethyl sulfoxide. IR studies provide evidence 
for the presence of an intramolecular hydrogen bond 
in the molecule and the antiparallel extended confor-
mation in chloroform solution. CD spectra in methanol, 
trifluoroethanol, and trimethyl phosphate indicate that 
the Dpg peptide shows slight conformational flexibil-
ity, whereas the folded Acsc analog is quite rigid. The 
extended Dpg peptide consistently shows the highest 
activity in human peripheral blood neutrophils, being 
-8 and 16 times more active than the parent peptide 
and the folded Ac6 c analog, respectively. However, the 
finding that all four peptides have ED5 o (the molar 
concentration of peptide to induce half-maximal en-
zyme release) values in the 10-8-10-9 M range suggests 
that an induced fit mechanism may indeed be important 
in this ligand-receptor interaction. Moreover, it is also 
possible that alterations in the backbone conformation 
at the tripeptide level may not significantly alter the 
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side chain topography and/or the accessibility of key 
functional groups important for interaction with the 
receptor. 
The discovery that formylmethionine- and formylmethio-
nine-containing peptides were chemoattractants for polymor-
phonuclear leukocytes (Schiffmann et al., 1975) initiated a 
series of studies aimed at identifying their structure-activity 
relationships (Showell et al., 1976; Freer et al., 1980). As a 
result, the tripeptide N-formyl-L-methionyl-L-leucyl-L-phen-
ylalanine (f'-Met-Leu-Phe-OH) emerged as the prototypic 
chemotactic tripeptide. It has been demonstrated that the N-
formyl-Met at position 1 and the Phe at position 3 are crucial 
for optimal activity, whereas alterations to the Leu at position 
2 are well tolerated, provided the substituted amino acid 
contains a bulky, hydrophobic side chain group (Freer et al., 
1982). Formyl-Met-Leu-Phe-OH is considered a pan-activa-
tor of neutrophils (PMNs) as it stimulates a wide range of 
PMN functions from chemotaxis and lysosomal enzyme re-
lease to superoxide generation (Becker, 1987). These effects 
are mediated by specific cell surface receptors (Aswanikumar 
et al., 1977; Williams et al., 1977) and a membrane protein 
which binds N-formylpeptides has recently been cloned from 
HL-60 cells (Boulay et al., 1990). 
Based on NMR (Becker et al., 1979) and x-ray diffraction 
data (Morffew and Tickle, 1981), a model which suggests an 
extended antiparallel ,6-sheet as the receptor-bound confor-
mation of f-Met-Leu-Phe-OH (Freer et al., 1982) has been 
proposed. Additional support for this hypothesis has come 
from several investigations (Bismara et al., 1985; Valensin et 
al., 1986; Toniolo et al., 1989a). However, the flexibility of the 
parent peptide has been established (Bakir and Stevens, 1982; 
Edmundson and Ely, 1985; Gavuzzo et al., 1989) and recent 
molecular modeling suggests that folded conformations of 
chemotactic peptides may be energetically favored (Semus et 
al., 1988; Feller and Zimmerman, 1989). Furthermore, confor-
mation-activity studies have revealed that the rabbit perito-
neal PMN is able to recognize stereochemically constrained, 
folded chemotactic peptide analogs (Iqbal et al., 1984; Suku-
mar et al., 1985). These folded analogs are nearly as potent or 
more potent than the parent peptide, depending on the size 
of the hydrophobic side chain group at position 2, and the 
nature of the C terminus. Additional work has led to the 
1 The abbreviations used are: f, formyl; Ac6c, 1-aminocyclohex-
anecarboxylic acid; (CH3 ) 4Si, tetramethylsilane; 2D COSY, two-di-
mensional correlated spectroscopy; Dpg, dipropylglycine; ED50, molar 
concentration of peptide to induce half-maximal enzyme release; 
HPLC, high performance liquid chromatography; LDH, lactate de-
hydrogenase; NOE, nuclear Overhauser enhancement; PMN, poly-
morphonuclear neutrophilic leukocyte; TEMPO, 2,2,6,6-tetramethyl-
piperidine-l-oxyl; TFE, trifluoroethanol. 
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proposal of a folded type II {J-turn as the receptor bound 
conformation (Raj, 1986; Toniolo et al., 1989b). These findings 
formed the rationale for our present investigation in which 
we describe the biological activity of a stereochemically con-
strained, extended chemotactic peptide analog as compared 
to a folded type II {J-turn analog in an attempt to assess the 
role of backbone conformation on secretagogue potency in the 
human peripheral blood neutrophil. The activity of the pep-
tides suggests that the chemotactic peptide receptor in human 
neutrophils has a definite preference for an extended peptide 
ligand. The results also emphasize that the difference in the 
backbone conformation of the tripeptides may not signifi-
cantly alter the topography of the side chains and accessibility 
of the functional groups for interaction with the receptor. 
EXPERIMENTAL PROCEDURES 
Selection of Peptides-N-Formyl-Met-Dpg-Phe-OMe was selected 
to generate a stereochemically constrained extended conformation 
based on theoretical and crystal structure studies which indicated 
that the Dpg residue is able to stabilize the extended backbone 
conformation (Benedetti et al., 1984; Bonora et al., 1984; Toniolo and 
Benedetti, 1988). N-Formyl-Met-Ac6c-Phe-0Me was chosen for in-
vestigation since it has been found to be more active than the parent 
peptide in stimulating lysosomal enzyme release from rabbit perito-
neal leukocytes, and its backbone conformational preference for a 
type II (:/-turn has been established (Toniolo et al., 1989b). Formyl-
Met-Leu-Phe-OH and its methyl ester derivative were also synthe-
sized and studied because of their high biological activity and their 
crystal and solution conformational properties have previously been 
established (Bakir and Stevens, 1982; Raj and Balaram, 1985). All 
four peptides were used as conformational probes to study the influ-
ence of peptide backbone conformation on secretagogue activity. 
Peptide Synthesis and Purification-All chemicals and solvents 
were of the highest purity available and used without further purifi-
cation. Tertiarybutyloxycarbonyl-L-methionine was purchased from 
Bachem (Torrance, CA). Phe-OMe hydrochloride, 1-hydroxybenzo-
triazole, and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide were 
from Sigma. Ac6c was obtained from Fluka Chemicals (Ronkonkoma, 
NY) and thionyl chloride, ethylcyanoacetate, and 1-bromopropane 
were from Aldrich Chemical Co. The peptides under study were 
synthesized as outlined in Fig. 1 by solution phase procedures using 
standard carbodiimide/1-hydroxybenzotriazole-mediated coupling 
(Konig and Geiger, 1970). The Dpg-OEt was synthesized as described 
by Hardy and Lingham (1983). The peptides were purified and 
analyzed on a Rainin Dynamax-60A reversed-phase C,8 column (10 
x 250 mm) coupled to a guard column (10 X 50 mm) employing an 
acetonitrile-water or methanol-water (each with 0.1 % trifluoroacetic 
acid) linear gradient elution (flow rate: 2.0 ml/min) mode with detec-
tion at 230 and 240 nm. The HPLC trace of the purified Dpg analog 
Chemoteclic Peptide Synthesis 
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FIG. 1. Scheme employed for solution-phase synthesis of N-
formylated chemotactic peptides. 1-Ethyl-3-(3-dimethylamino-
propyl)carbodiimide (EDC)/1-hydroxybenzotriazole (HOBt) me-
diated coupling procedures were employed using methylene chloride 
(CH,Cl,) and N,N-dimethyl formamide (DMF) to solubilize Boe-
amino acids and Boe-protected dipeptides, respectively. 
is shown in Fig. 2. The purity of the peptides was also checked on 
thin-layer chromatography by three different solvent systems 
(CHCls/MeOH (95:5), n-1-butanol/acetic acid/H20 (4:1:1), and 
CHCla/EtOH (9:1)) using iodine stain for detection. For biological 
assays the purified peptides were stored in glass ampules, sealed 
under nitrogen, and kept at -70 °C until the day of the assay. 
X-ray Crystallographic Analysis-Single crystals of N-formyl-L-
Met-Dpg-L-Phe-OMe were grown by slow evaporation from a mixture 
of benzene and hexane, C2,H3,N305S · 2/3(C6H6) fw = 531.6. The 
tripeptide crystallizes in an orthorhombic unit cell with dimensions 
of a = 12.204 A, b = 20.226 A, c = 23.961 A; space group I222. There 
are eight peptide molecules per unit cell of volume 5914.8 A3• X-ray 
diffraction data was collected on an Enraf-Nonius CAD4 diffrac-
tometer equippe9" with a graphite monochromator using CuK" radia-
tion (1 = 1.54 A), and all calculations were performed on a VAX 
computer using SDP /VAX (Frenz, 1985). The crystal structure was 
solved by the application of direct methods using SHELXS-86 (Sheld-
rick, 1985) and successive weighted Fourier maps. Full-matrix least 
squares were used for refinement, with atoms being treated isotropi-
cally in the initial stages and with anisotropic parameters in the final 
stages of refinement. Hydrogen atoms were not included in the 
calculations. The final weighted R factor for 2586 reflections where I 
> 2s was 0.085. The structure shown in Fig. 3A was plotted with the 
ORTEP computer program (Johnson, 1965). (A list of atomic coor-
dinates and structure factor tables are available upon request.) 
Spectroscopic Studies-The 500-MHz 'Hand 125-MHz "1C NMR 
spectra were recorded using a Varian VXR-500 NMR spectrometer 
equipped with a SUN 3/110 computer. The concentration of peptide 
used for the two-dimensional correlated spectroscopy (2D COSY) and 
difference nuclear Overhauser enhancement (NOE) studies were 25 
and 10 mM in (CD,1),SO and CDCl:i, respectively. Peptide concentra-
tion for all other NMR studies was 2 mM. In the NOE studies, the 
perturbed and normal spectra were recorded sequentially in different 
parts of the memory, each with 16 K data points. The perturbed and 
normal spectra were obtained with low-power on-resonance satura-
tion of a peak and by off-resonance shifting of the irradiation fre-
quency, respectively. IR spectra were recorded on a Bio-Rad FTS-40 
spectrometer. Solutions of the peptide were prepared in dry CHCh 
and spectra recorded using pathlengths from 1 to 5 mm. CD spectra 
were recorded on a Jasco J-600 spectropolarimeter interfaced with an 
IBM PS/2 microcomputer with measurements carried out at 22 °C 
using a 0.1-mm pathlength and 2 mM peptide concentrations. 
Neutrophil Isolation-Whole blood was collected by venipuncture 
from healthy human volunteers and diluted (6:1) in acid citrate 
dextrose anticoagulant. The neutrophils (PMN) were isolated using 
Histopaque gradients followed by dextran sedimentation and hypo-
tonic lysis as described by Metcalfe et al., 1986. PMN were washed 
twice and resuspended in Dulbecco's phosphate-buffered saline with 
0.1 % bovine serum albumin and 0.1 % glucose, pH 7.3. Cell purity was 
assessed by Wright-Giemsa stain and was routinely 95-97% PMN. 
Enzyme Release Assays-Peptide-induced degranulation (release 
of (:i-glucuronidase) was assessed as a measure of biological activity. 
Lactate dehydrogenase (LOH) released from the cytoplasm was meas-
ured to determine cell viability at the end of each assay. This value 
never exceeded 5% of the total LOH. The secretagogue activity of 
each peptide was tested at eight different concentrations using a 
timed assay. Briefly, PMNs (1 X 107 /ml) in Oulbecco's phosphate-
~ 
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NO 
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C 
ro 
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FIG. 2. HPLC trace of the purified f-Met-Dpg-Phe-OMe on 
a Rainin Dynamax-60A reversed phase C18 column (10 x 250 
mm) using acetonitrile and water as the solvent system (flow 
rate: 2 ml/min). The peptide (100 µg) was loaded into an injection 
loop of 100-µl capacity and detected at 230 nm. The gradient used is 
shown as a dashed line. 
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A 
CJZ 
(0.5+x, 0.5-y, 0.5-z) ( ·0.S+x, ·O. 5-y, ·O. 5-z) 
FIG. 3. A, a perspective view of the molecular conformation of f-Met-Dpg-Phe-OMe showing the atomic 
numbering scheme used. Hydrogen atoms are not included in the fig. for clarity. B, the intermolecular association 
of the peptide molecules involving the asymmetric unit (x, y, z) as viewed from the crystallographic c axis. The 
intermolecular hydrogen bonds (dashed lines) formed between Met NH (Nl) and Dpg CO (02) groups (2 - x, - y, 
z) of symmetry related molecules forming antiparallel /3-strands and between Phe NH (N3) and Met CO (01) 
groups (-0.5 + x, -0.5 - y, -0.5 - z, and 0.5 + x, 0.5 - y, 0.5 - z) of symmetry-related molecules giving rise to 
parallel /3-strands are shown. 
buffered saline with cytochalasin B (final assay concentration of 5 
µg/ml) were aliquoted (0.75 ml) into 1.75-ml polypropylene tubes 
containing 0.6 ml of Dulbecco's phosphate-buffered saline and al-
lowed to equilibrate at 37 °C in a shaking water bath for 5 min. The 
peptide stimulus was added (0.15 ml) and the mixture incubated for 
20 min before being placed on ice and subsequently centrifuged at 
800 X g for 5 min at 4 °C to pellet the cells. PMN supernatants were 
then tested in duplicate for the presence of these enzymes as previ-
ously described (Metcalfe et al., 1986). Maximum stimulated release 
was calculated as a percentage of the total enzyme present. Total /3-
glucuronidase and LDH was determined by adding 0.3% (v/v) Triton 
X-100 and vortexing for 2 min prior to centrifugation. Controls run 
for each experiment included spontaneous release (no peptide stim-
ulus) and total release of both enzymes in the presence and absence 
of cytochalasin B, and spontaneous release at the highest (CH3}eSO 
concentration run in the experiment. This value never exceeded 0.5% 
(CH,) 2SO. To control for donor variability and to get a relative 
measure of their activity all four peptides were tested in each exper-
iment and their potency relative to the parent peptide calculated as 
EDr,o f-Met-Leu-Phe-OH/ED50 test peptide. Pilot studies were run 
where total enzyme release was assessed in the presence and absence 
of high concentrations of each peptide (10 µM) to insure that the 
peptides were not interfering with the detection of enzyme activity. 
Additionally, kinetics experiments revealed that the degranulation 
response was essentially complete by 5 min; however, we chose a 20-
min incubation time for convenience since the spontaneous release 
of both LDH and /3-glucuronidase did not increase significantly over 
this time interval. Dose-response curves were generated from each 
experiment using the Sigma-Plot program (Jandel Scientific Corp., 
Corte Madera, CA) and the ED50 values taken directly from the 
graphs. (See Fig. 11 for a composite graph from five experiments 
showing the average values of enzyme release for each peptide at 
eight different concentrations.) The error bars represent the standard 
error of the means. A third order polynomial gave the best fit to these 
data with R values above 0.99 for each of the four curves shown. 
RESULTS AND DISCUSSION 
Molecular Structure 
The molecular structure of f-Met-Dpg-Phe-OMe is shown 
in Fig. 3A and the relevant torsional angles are provided in 
Table I. The peptide molecules assume an extended /3 confor-
mation with a twist both at the N and C termini of the peptide 
backbone. The Dpg residue at position 2 has the </> and f 
values of 173.1 ° and 179.0°, respectively, and adopts an ex-
tended conformation with a short contact between the NH 
and CO groups giving rise to a C5 ring structure (N2H- - -02 
= 2.074 A; r angle (N2-C2A-C'2) = 105.4 °) (Toniolo, 1980, 
1989). Similar C5 structures have been observed for the Dpg 
TABLE I 
Relevant torsional angles (0) for f-Met-Dpg-Phe-OMe 
The torsional angles for rotation about bonds of the peptide back-
bone(</>,>/;, w) and side chains (x1, x'', x 2, x 2 ', x 3) are described as 
in IUPAC-IUB Commission on Biochemical Nomenclature (1970). 
w 
x' 
x" 
x' 
x2, 
Met Dpg Phe 
-75.8 (6) 0 173.1 (4) -96.7 (6) 
-30.4 (6) 179.0 (4) 33.6 (6) 
178.9 (4) 173.1 (4) -178.3 (6)b 
57.4 (6) -62.3 (5) -58. 7 (7) 
178.2 (4) 
53.2 (5) 
176.8 (6) 
175.4 (5) 
106.5 (9) 
-65 (1) 
x3 -74.6 (7) 
0 Estimated standard deviations are in parentheses. 
b With 04C24 of the carboxymethyl group. 
residue in the crystal structures of homooligopeptides con-
taining dipropylglycines (Benedetti et al., 1984; Toniolo and 
Benedetti, 1988). The </> and f values for the Met and Phe 
residues (Table I) are much lower than the </> and f values 
(-130°, ±135°, respectively) observed for oligopeptides exhib-
iting ideal extended /3-sheet structures (Karle et al., 1983, 
1988). The lower </> and f values of the Met and Phe residues 
cause a twist in the extended backbone of the peptide. Twisted 
antiparallel /3-sheet structures have been observed in the 
crystals of oligopeptides containing L-cystine (Karle et al., 
1989; Raj et al., 1990) and in globular proteins (Chothia, 1973; 
Salemme and Weatherford, 1981; Richardson, 1981). Inter-
estingly, the symmetry of the Dpg residue results in the 
disposition of a hydrophobic propyl chain adjacent to both 
the Met and Phe side chain groups even though the Met and 
Phe side chains lie on opposite sides of the peptide backbone. 
The hydrogen bonding pattern between the tripeptide mol-
ecules is shown in Fig. 3B and the geometry of the hydrogen 
bonds is provided in Table II. There are four intermolecular 
hydrogen bonds involving the asymmetric unit (x, y, z). As-
sociation of the peptide molecules in the crystal is character-
ized by a network of intermolecular hydrogen bonds formed 
between Met NH (Nl) and Dpg CO (02) groups (2 - x, -y, 
z) of symmetry related molecules forming antiparallel /3-
strands and between Phe NH (N3) and Met CO (01) groups 
(-0.5 + x, -0.5 - y, -0.5 - z, and 0.5 + x, 0.5 - y, 0.5 - z) of 
symmetry related molecules giving rise to parallel /3-strands. 
The Nl- - -02 and N3- - -01 distances, 2.854 and 2.915 A, 
Structure-Function Analysis of Chemotactic Tripeptide Analogs 
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Geometry of the hydrogen bonds observed in the f-Met-Dpg-Phe-OMe 
crystal structure 
D H A D-H D ... A H ... A D-H ... A Code" 
A 
Nl NlH2 02 0.951 2.854 1.944 
N3 N3H24 01 0.972 2.915 2.000 
159.2 
156.0 
1 
2 
"(1) NlH2 (x, y, z) ... 02 (2 -x, -y, z) and NlH2 (2 -x, -y, z) ... 02 
(x, y, z); (2) N3H24 (x, y, z) · · -01 (0.5 + x, 0.5 - y, 0.5 - z) and 
N3H24 (-0.5 + x, -0.5 - y, -0.5 - z). · -01 (x, y, z). 
FIG. 4. Crystal packing of f-Met-Dpg-Phe-OMe and ben-
zene solvent molecules in the unit cell. Eight peptide molecules 
in the orthorhombic unit cell are shown along with the benzene 
solvent molecules. Alternating hydrophobic and hydrophilic channels 
exist within the lattice along both the crystallographic a and c axes. 
respectively, agree well with the average value observed in the 
crystals of chemotactic peptide analogs (Eggleston, 1988, 
1990; Gavuzzo et al., 1989). It is quite unusual to observe that 
the Dpg CO group which shows a short intramolecular 
NH- - -0 contact with the Dpg NH group, is also involved in 
intermolecular association. The much lower </J and -./; angles 
observed for Met (-75.8°, -30.4°) and Phe (-96.7°, 33.6°) 
residues in the crystal structure may presumably be due to 
the involvement of the NH groups of these residues in strong 
intermolecular hydrogen bonding within the lattice structure. 
The twist observed in the peptide backbone can be attributed 
to these intermolecular hydrogen bonds as well as other 
hydrophobic/hydrophilic crystal packing forces. 
Crystal Packing 
The crystal packing of peptide and benzene solvent mole-
cules in the unit cell is shown in Fig. 4. Alternating hydrophilic 
and hydrophobic channels exist within the lattice along both 
the crystallographic a and c axes. At the edges and at the 
center of the unit cell, there is a clustering of aromatic rings 
from the Phe side chains and the benzene molecules along 
the a axis, which results in the formation of aromatic channels 
passing through the lattice in this direction. In contrast, 
hydrophilic channels exist above and below the central aro-
matic channel along the a and c axes where parallel and 
antiparallel hydrogen bonds are formed between adjacent 
peptide molecules. 
NMR Studies in Solution 
Assignment of Resonances-The 500 MHz 'H- and 125-
MHz 1'1C NMR spectra of the Dpg analog shown in Fig. 5 are 
fully consistent with its primary structure. The singlet reso-
nance that occurs at 8.1-8.2 ppm both in CDC13 and ( CDJ280 
was recognized as the formyl proton by its characteristic 
chemical shift while the Dpg NH resonance was unambigu-
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FIG. 5. 500 MHz 1H (A) and 125 MHz 13C (B) NMR spectra 
of f-Met-Dpg-Phe-OMe (2 mM) in (CD3 ).SO at 25 °C. 
ously recognized as the other singlet resonance at 7.38 ppm 
in (CD:1)280. In CDCb, it was buried under the aromatic 
resonances, and it was assigned by solvent titration experi-
ment (Fig. 6A). The Met and Phe doublet resonances in these 
solvents were assigned by spin decoupling experiments. In 
(CD3)z80, the spin system connectivities of NH, C"H, C#H2, 
C1 H 2 , and C'H:1 resonances were also established from the 
2D COSY spectrum (Fig. 7). 
Delineation of Hydrogen-bonded NH Groups-The involve-
ment of NH groups in intramolecular hydrogen bonding was 
probed using solvent and temperature-induced NH chemical 
shifts, paramagnetic radical-induced line broadening, and hy-
drogen-deuterium exchange effects on NH resonances (Kop-
ple and Schamper, 1972; Ohnishi and Urry, 1972; Pitner and 
Urry, 1972; Wuthrich, 1976; Kessler, 1982). The results are 
summarized in Fig. 6 and 'H NMR parameters are provided 
in Table III. A peptide concentration of -2 mM was used to 
avoid the influence of peptide aggregation on the 'H NMR 
parameters (Raj and Balaram, 1985). In the solvent titration 
experiment (Fig. 6A), the Met and Phe NH resonances show 
substantial downfield shifts (2.1 and 2.2 ppm, respectively) 
with increasing concentrations of (CD3)z80, while the Dpg 
NH resonance shows only a slight downfield shift of 0.3 ppm 
(Table III). In (CD3)z80, the temperature coefficient (do/dT) 
of the Dpg NH is quite low (0.0009 ppm/K) indicating solvent-
shielding of this NH group, whereas the Met and Phe NH 
groups show relatively high do/dT values of 0.0048 and 0.0054 
ppm/K, respectively, suggestive of NH groups which are freely 
accessible to the solvent (Fig. 68). Likewise, addition of the 
paramagnetic radical probe 2,2,6,6-tetramethylpiperidine-l-
oxyl (TEMPO) to the peptide in CDCb solution results in a 
dramatic broadening of the Met and Phe NH resonances, 
whereas the Dpg NH resonance is much less affected (Fig. 
6C). Furthermore, the rate of deuterium-hydrogen exchange 
in (CD3)z80 is substantially faster for the Met and Phe NH 
resonances than for the Dpg NH resonance (Fig. 6D). These 
findings suggest that both the Met and Phe NH groups are 
freely accessible to the solvent and not involved in hydrogen 
bonding while the Dpg NH is inaccessible to the solvent and 
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FIG. 6. Delineation of hydrogen- ... , ... 
bonded NH groups in f-Met-Dpg- • 10 .. 2IO .. ... 
-
••• "" 
... 
Phe-OMe. A, solvent dependence of NH "(CD3)250 T (K) 
chemical shifts in CDCb-(CD"hSO mix-
tures as a function of solvent concentra-
tion. B, temperature dependence of NH C 
chemical shifts in (CD3 ) 2SO. The tern-
perature coefficients, do/dT (ppm/K) of J: 
>, the NH resonances are shown in the E 
traces. C, line-broadening of NH reso- 0 
nances with increasing concentration of 11. 
TEMPO radical in CDCb containing 
0.10% TEMPO 0.6% (CD:ihSO. TEMPO concentration 
is indicated on the traces. D, the effect 
of hydrogen-deuterium exchange on NH 
resonances in (CD3 ) 2SO. Time intervals 
after the addition of 3% D20 (v/v) are 
indicated on the traces. A peptide con- 0.08% TEMPO 
centration of 2 mM was used in all ex-
periments. 
0.04% TEMPO 
o,-. TEMPO 
R.2 7.6 
is presumably hydrogen bonded both in (CD3)zS0 and CDCb. 
This shielding is consistent with the crystal structure analysis 
which has established the intramolecular short contact be-
tween the Dpg NH and the Dpg CO groups as part of a C5 
ring structure. The JNH-C"H values (7.6-8.1 Hz) observed for 
Met and Phe residues in CDCls and (CD3)2SO shown in Table 
III suggest values for </> of --90° and --150° (Karplus 1963; 
Pardi et al., 1984). Both these values and the absence of 
intramolecular hydrogen bonding of the Met and Phe NH 
resonances provide evidence in favor of an extended peptide 
backbone structure in (CD3)2SO and CDCls. In addition, the 
</> value (-90°) for the Phe residue deduced from NMR data 
is in close agreement with the value obtained from the crystal 
structure. Furthermore, the unusual chemical shift difference 
between the Dpg C11HA and Cl'HB in CDCls and (CD3)zSO (-1 
ppm) as well as c~HA and c~HB resonances in (CD3)2SO (Fig. 
5A) suggests a ring current effect from the adjacent Phe side 
chain (Bovey et al., 1988). This is also consistent with the 
crystal structure (Fig. 3A) where the Phe side chain is in a 
position to exert a substantial shielding effect on these pro-
tons. Taken together, these data indicate that the Dpg analog 
has a preference for an extended (3 structure in solvents of 
widely varying polarities and hydrogen bonding capabilities 
and the solution conformation is in good agreement with the 
crystal structure. 
NOE Studies 
NOE studies were carried out to provide additional infor-
mation on the backbone conformation (Rao et al., 1983). 
Extended antiparallel (3 structures can be recognized by the 
M 
0 
J: D 0 
cl J: ; J: 
" z J: J: :i:: :i:: >, :x: ~ R z z z E z ii • z <O .c ii ... if ~ :::E ll.. .c .... - - ~ Q. 0 
T • 240 MIN 
l T.60MIN L 
T • SMIN J_ 
T = OMIN 1 
7.0 6.4 (ppm) 8.5 8.0 7.5 
observation of NOEs between the CtH and N;+1H, since the 
distance between these nuclei is <3 A (Kuo and Gibbons, 
1980; Billeter et al., 1982). The results are summarized in 
Table IV. Fig. 8 shows a representative one-dimensional dif-
ference NOE spectra in CDC13 where the Phe NH has been 
irradiated and an intensity enhancement of 3.6% for Dpg 
C~HB and 3.0% for the cwHB is observed. Irradiation of the 
Dpg NH resonance gives rise to 4.1 % ((CD3)zS0) and 7.8% 
(CDCls) of NOEs on the Met C"H resonance. In the reverse 
experiment, the irradiation of the Met C"H gives rise to NOEs 
on the Dpg NH (Table IV). NOEs are also observed between 
the formyl proton and the Met NH both in CDCls and 
(CD3)2SO, suggesting that the formyl H and Met NH are in 
cis geometry as observed in the crystal structure (Fig. 3A). 
The observed interresidue NOEs are consistent with an ex-
tended antiparallel (3 conformation where NOE connectivities 
are expected between the formyl H and Met NH, between the 
Met C"H and Dpg NH, and between Phe NH and Dpg C~H, 
c~·H (Kuo and Gibbons, 1980; Billeter et al., 1982), A graphic 
representation of the through-space connectivities and the 
proposed antiparallel (3 conformation shown in Fig. 8 are 
consistent with the NOE data in CDCls and (CD3)2SO solu-
tions. 
Fourier Transform Infrared Studies 
The NH and CO stretching regions in the IR spectra of the 
Dpg analog in CHCls solutions are shown in Fig. 9. Even at 
low concentrations (3 x 10-4 M) the peptide shows a weak 
band at 3359/cm (Fig. 9A) which is characteristic of a hydro-
gen bonded NH in addition to the free NH band at 3427 /cm 
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FIG. 7. 500 MHz 1H NMR 2D COSY contour plot of f-Met-Dpg-Phe-OMe in (CD3hS0 with spin 
system connectivities. A, NH-C"H connectivities, 3.9-8.7 ppm; B, C"H-C~H, C'H, and C'H connectivities, 0-
4.8 ppm (illustrated by dashed lines). 
TABLE III 
NH group" NMR parameters for f-Met-Dpg-Phe-OMe 
Parametersb 
t.o(ppm) = o[(CD3),SO] - o(CDCla) 
do/dT(ppm/K) (CD3)2SO 
JNH-C°'H (Hz) CDCb 
JNH-C°'H (Hz) (CDa),80 
" Peptide concentration = -2 mM. 
Met-NH' Dpg-NH Phe-NH 
2.1 0.3 2.2 
0.0048 0.0009 0.0054 
7.8 7.8 
7.6 8.1 
h Assignments made as described in the text. 
TABLE IV 
One-dimensional difference NOE data" for f-Met-Dpg-Phe-OMe 
NOE 
Irradiated Observed 
CDC'3 (CD 3) 2SO 
% 
Formyl H Met NH 4.0 0.1 
Met NH Formyl H 3.7 8.7 
MetC"H DpgNH 4.1 b 1.5 
DpgNH Met C"H 7.81 4.1 
PheNH DpgC~HB 3.6 2.2 
DpgC~'HB 3.0 1.6 
"Only interresidue NOEs are tabulated. 
b The percentage NOEs between the Met C"H and Dpg NH have 
been assessed in CDCb with 0.6% (CD3),SO, as the NH resonance in 
the off-resonance spectrum in CDCb is buried under the aromatic 
resonances. 
(Bonora et al., 1984). The band observed at 3359/cm even at 
low concentrations suggests the presence of a weak intramo-
lecular hydrogen bond in the peptide molecule (Bardi et al., 
1985; Raj et al., 1988), which is consistent with both the 
crystal structure and the NMR data. In the carbonyl-stretch-
ing region (Fig. 9B) the weak band observed at 1692/cm 
provides further support for an extended structure (Miyazawa, 
1967). However, an exciton split of only 29/cm is observed at 
high concentrations suggesting that ~-sheet structures formed 
by aggregation of the peptide molecules are not fully antipar-
allel. The exciton split is increased to 45/cm at low concen-
tration presumably due to the formation of a more orderly 
extended conformation of the peptide backbone (Krimm and 
Bandekar, 1986). 
CD Studies 
Circular dichroism studies were carried out on both the Dpg 
peptide and the Ac6c peptide in methanol (MeOH), trifluo-
roethanol (TFE), and trimethyl phosphate (TMP) in an at-
tempt to assess the solvent dependent conformational change 
of the peptide backbone. The CD spectra of the Dpg and Ac6c 
analogs recorded between 175 and 250 nm in these solvents 
are shown in Fig. 10, and the CD parameters are summarized 
in Table V. Though CD is a sensitive technique for the 
prediction of secondary structure of polypeptides (Beychok, 
1967), the limitations on the use of CD for conformational 
analysis of small linear peptides with aromatic residues, such 
as those studied here, have been reported (Toniolo and Bon-
ora, 1976; Toniolo et al., 1989a). However, CD studies do 
provide useful information on the relative conformational 
flexibility of these two constrained peptides. The Dpg peptide 
exhibits a weak positive CD band at -215-220 nm (Fig. lOA) 
and an intense negative band at -190-195 nm in MeOH and 
TMP. In TFE, it exhibits a positive shoulder at -213 nm, a 
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FIG. 8. 500 MHz 'H NMR off-res-
onance spectrum of f-Met-Dpg-Phe-
OMe in CDCla (top). The NOEs ob-
served on Phe C"H, Dpg C#H8 , and 
C1''He resonances are shown in the dif-
ference NOE spectrum (bottom) ob-
tained by saturation of Phe NH. The 
proposed antiparallel {3 conformation of 
the peptide in solution is also shown. 
The arrows indicate the protons that 
give rise to interresidue NOEs. 
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FIG. 9. Partial IR spectra of f-Met-Dpg-Phe-OMe in dry 
CHCla at various concentrations indicated against the traces. 
A, NH stretching region showing free NH bands at 3420/cm and 
hydrogen-bonded NH band at 3359/cm. B, CO stretching region 
showing the strong bands at 1745 and -1663/cm and a weak band at 
1692/cm. Note the shift in the strong band from 1663 to 1647/cm as 
the peptide concentration is decreased to 3 X 10-• M. 
A B 
190 205 220 235 
'" 
WAVELENGTH (nm) 
FIG. 10. CD spectra of stereochemically constrained for-
mylpeptides. f-Met-Dpg-Phe-OMe (A) and f-Met-Ac6c-Phe-0Me 
(B) in TFE, trimethyl phosphate (TMP), and methanol (MeOH) at 
2 mM peptide concentration. 
positive maximum at -193 nm, and a strong negative mini-
mum at -183 nm. The reported CD spectrum of the parent 
chemotactic peptide, f-Met-Leu-Phe-OH which has been es-
tablished to adopt an extended {3 conformation in the solid 
state by x-ray diffraction and in solution by NMR is quite 
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TABLE V 
CDa parameters for chemotactic peptide analogs 
f-Met-Dpg-Phe-OMe 
A (nm) 
[/i]M 
A (nm) 
[/i]M 
A (nm) 
[/i]M 
f-Met-Ac6c-Phe-0Me 
A (nm) 
[/i]M 
A (nm) 
[/i]M 
A (nm) 
[/i]M 
MeOH 
219 
+ 13051 
192 
-32193 
209 
+9041 
196 
+18151 
186 
-14047 
a Peptide concentration: -2 mM. 
TMP 
220 
+8551 
189 
-52353 
220 
+17524 
196 
+44257 
186 
-53845 
b [/i]M is molar ellipticity expressed as deg cm2 dmol-1. 
TFE 
213 
+6121 
193 
+10048 
183 
-36248 
212 
+18892 
194 
+47948 
184 
-51031 
similar in TFE (Bakir and Stevens, 1982). The folded Ac6c 
analog shows two weak shallow positive bands between 194 
and 220 nm in all three solvents with a maximum at -196 
and a strong negative band at -186 nm. Similar CD spectra 
observed for the pentapeptide Tyr-Pro-Gly-Asp-Val in water 
(Dyson et al., 1988) and for pivaloyl-L-prolyl-a-aminoisobu-
tyryl-N-methylamide in MeOH (Crisma et al., 1984) have 
been interpreted in terms of a {3-turn conformation, which is 
consistent with the previously established {3-turn structure of 
f-Met-Ac6c-Phe-0Me (Toniolo et al., 1989b). Even though it 
is not safe to relate CD spectra of linear oligopeptides in terms 
of any specific conformation, it appears from CD studies that 
the stereochemically constrained, extended Dpg peptide 
shows some conformational flexibility, whereas the folded 
Ac6c analog appears quite rigid. 
Biological Activity Studies 
The peptides were examined for their ability to induce the 
release of {3-glucuronidase from cytochalasin B-treated human 
peripheral blood neutrophils. The dose-response curves for /3-
glucuronidase release and ED5o values (the molar concentra-
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FIG. 11. Dose-response curves generated using the Sigma-
Plot program (Jandel Scientific Corp., Corte Madera, CA) for 
formylpeptide-induced .B-glucuronidase release from human 
neutrophils. ED50 values taken from the curves and the potency 
ratio (ED.so of f-Met-Leu-Phe-OH/EDso of test peptide) are also 
shown. The error bars represent the standard error of the means 
calculated from the percentage release values of five separate exper-
iments. A third order polynomial gave the best fit to these data with 
R values above 0.99 for each of the four curves shown. 
tion of the peptide which would induce half-maximal enzyme 
release) are provided in Fig. 11. The maximum formylpeptide-
induced release of /J-glucuronidase ranged from 40 to 45% of 
the total amount of enzyme detectable with f-Met-Dpg-Phe-
OMe consistently showing 3-5% higher maximum release 
values than the other three peptides tested. In addition to its 
slightly higher efficacy, f-Met-Dpg- Phe-OMe was consistently 
the most potent secretagogue for the human PMN, being -8-
and 16-fold more active than the parent peptide and the 
folded Ac6c analog, respectively. We also found f-Met-Ac6c-
Phe-0Me and f-Met-Leu-Phe-OMe to be consistently less 
active (-0.5 X) than the parent peptide (f-Met-Leu-Phe-OH). 
It is worth mentioning that these same two peptides have 
been shown to be -5 x more active than the parent peptide, 
when tested on rabbit peritoneal neutrophils (Sukumar et al., 
1985; Toniolo et al., 1989b). The ED50 observed for f-Met-
Leu-Phe-OMe (Fig. 11) is in good agreement with a previously 
published report (Belleau et al., 1989). It is noteworthy that 
for these tripeptides the simple conversion of the C-terminal 
functional group from a carboxylic acid to the methyl ester 
results in a loss of secretagogue activity in human peripheral 
blood neutrophils. The finding that f-Met-Ac6c-Phe-0Me is 
equipotent to f-Met-Leu-Phe-OMe suggests that the replace-
ment of the Leu side chain at position 2 by a cyclohexane 
ring does not substantially alter peptide activity. 
Conformation and Biological Activity 
Despite the methyl ester function at the carboxyl terminus, 
f-Met-Dpg-Phe-OMe is -8 x more potent than the parent 
peptide and 16 x more potent than f-Met-Ac6c-Phe-0Me. 
The enhanced activity of the extended Dpg analog and the 
decreased activity of the folded Ac6c analog relative to the 
parent peptide suggest that the extended backbone may be 
the preferred ligand conformation for the human neutrophil 
chemotactic peptide receptor. This is consistent with Freer's 
original proposal that the receptor-bound conformation off-
Met-Leu-Phe-OH is an extended /J-structure (Freer et al., 
1982). However, our findings do not rule out the possibility 
that other factors are responsible for these alterations in 
biological activity. 
In addition to peptide backbone conformation, the topog-
raphy of the side chain groups will also influence activity. 
The side chain orientation may in part account for the in-
creased potency of the Dpg analog. One can speculate that 
the inherent symmetry of bilateral propyl side chains of Dpg 
essentially increases the total number of side chains in the 
tripeptide from three in the parent peptide to four in the Dpg 
analog (Fig. 1A). This may increase the probability of having 
three side chain groups of the peptide aligned in a favorable 
orientation for binding to the receptor. In this regard it should 
be noted that when f-Met-Leu-Phe-OH was cocrystallized 
with a protein receptor the preferred orientation of the Met, 
Leu, and Phe side chains showed the three hydrophobic 
groups on one face of the peptide backbone swept back into a 
hydrophobic pocket (Edmundson and Ely, 1985). Since side 
chain group topography and peptide backbone conformation 
are intimately associated (Lyu et al., 1990) one must also 
consider that these two factors together may affect the surface 
accessibility of some as of yet unidentified critical backbone 
functional group in the initial binding interaction between 
the peptide and receptor. This latter possibility may be very 
important if an induced fit mechanism is at work. Moreover, 
it may be possible for peptides with different backbone con-
formations to display similar side chain orientations (Hruby 
et al., 1990). Other possibilities which cannot be ruled out on 
the basis of this work include susceptibility of the different 
peptides to enzyme degradation or the presence of more than 
one receptor on the human PMN. 
In summary, we have synthesized a unique chemotactic 
peptide analog f-Met-Dpg-Phe-OMe and shown that the pep-
tide prefers an extended backbone conformation both in so-
lution and in the solid state with a C5 conformation at 
position 2. We have assessed the biological activity of this 
peptide in human neutrophils and found it to be a more potent 
secretagogue than the stereochemically constrained type II /J-
turn folded chemotactic peptide analog (f-Met-Ac6c-Phe-
0Me) and the unconstrained parent peptides (f-Met-Leu-
Phe-OMe and f-Met-Leu-Phe-OH). While these findings are 
consistent with the hypothesis that a formylpeptide receptor 
prefers a ligand with an extended peptide backbone (Freer et 
al., 1982), the biological activity of all four peptides (EDso 
-10-8-10-9 M) provides indirect evidence in support of the 
induced fit mechanism originally proposed by Edmundson 
and Ely (1985). It should also be noted that the importance 
of side chain topography is as yet undefined for the formyl-
peptides. This may be important particularly at the tripeptide 
level where the orientation of the side chains in either a folded 
or extended tripeptide may be similar enough to activate the 
receptor. Finally, we have observed that in the human PMN 
model system f-Met-Leu-Phe-OMe and f-Met-Acsc-Phe-OMe 
are less active than f-Met-Leu-Phe-OH. This is in contrast 
to the findings in the rabbit peritoneal neutrophil model 
(Sukumar et al., 1985; Toniolo et al., 1989b) where the methyl 
ester derivatives are reported to be more potent than the 
parent peptide. 
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